{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import networkx as nx\n",
    "from networkx.algorithms import bipartite\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "import load\n",
    "import descriptions\n",
    "import matplotlib.pyplot as plt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "tables = load.all_tables(add_descriptions=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = ABIRATERONE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = ATG',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = BENDAMUSTINE',\n",
       "  {'weight': 10}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = BEVACIZUMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = BLEOMYCIN',\n",
       "  {'weight': 18}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = CAPECITABINE',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = CARBOPLATIN',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = CARMUSTINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = CISPLATIN',\n",
       "  {'weight': 26}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 26}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = DACTINOMYCIN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = DOCETAXEL',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = DOXORUBICIN',\n",
       "  {'weight': 26}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = EPIRUBICIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = ETOPOSIDE',\n",
       "  {'weight': 28}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = FLUCONAZOLE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = FLUOROURACIL',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = GEMCITABINE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = HYDROXYCARBAMIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = IFOSFAMIDE',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = MERCAPTOPURINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = MESNA',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = METHOTREXATE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = MITOMYCIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 129}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = NOT MATCHED',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = OBINUTUZUMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = OXALIPLATIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = PACLITAXEL',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = PEMETREXED',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 71}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = RUXOLITINIB',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 21}),\n",
       " ('MAPPED_REGIMEN = 111 Trial (formerly BEP 111)',\n",
       "  'DRUG_GROUP = VINCRISTINE',\n",
       "  {'weight': 29}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL',\n",
       "  'DRUG_GROUP = ABIRATERONE',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL', 'DRUG_GROUP = AXITINIB', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL',\n",
       "  'DRUG_GROUP = BENDAMUSTINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL',\n",
       "  'DRUG_GROUP = BICALUTAMIDE',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL',\n",
       "  'DRUG_GROUP = CAPECITABINE',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL', 'DRUG_GROUP = CISPLATIN', {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL',\n",
       "  'DRUG_GROUP = CYPROTERONE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL', 'DRUG_GROUP = DENOSUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL', 'DRUG_GROUP = DOCETAXEL', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL',\n",
       "  'DRUG_GROUP = ENZALUTAMIDE',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL',\n",
       "  'DRUG_GROUP = EPIRUBICIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL',\n",
       "  'DRUG_GROUP = EVEROLIMUS',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL',\n",
       "  'DRUG_GROUP = FLUCONAZOLE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL',\n",
       "  'DRUG_GROUP = FLUOROURACIL',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL',\n",
       "  'DRUG_GROUP = GEMCITABINE',\n",
       "  {'weight': 16}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL', 'DRUG_GROUP = MULTIPLE', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL',\n",
       "  'DRUG_GROUP = NAB-PACLITAXEL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 17}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL',\n",
       "  'DRUG_GROUP = OXALIPLATIN',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL', 'DRUG_GROUP = PAZOPANIB', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL', 'DRUG_GROUP = STEROID', {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL', 'DRUG_GROUP = SUNITINIB', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL',\n",
       "  'DRUG_GROUP = VINCRISTINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = A-PREDICT TRIAL',\n",
       "  'DRUG_GROUP = ZOLEDRONIC ACID',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABC-02 TRIAL', 'DRUG_GROUP = CARBOPLATIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABC-02 TRIAL', 'DRUG_GROUP = CISPLATIN', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ABC-02 TRIAL', 'DRUG_GROUP = GEMCITABINE', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ABC-02 TRIAL', 'DRUG_GROUP = IMATINIB', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ABC-02 TRIAL', 'DRUG_GROUP = MITOMYCIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABC-02 TRIAL', 'DRUG_GROUP = NOT CHEMO', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ABC-02 TRIAL', 'DRUG_GROUP = PEMETREXED', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ABC-02 TRIAL', 'DRUG_GROUP = STEROID', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ABC-02 TRIAL', 'DRUG_GROUP = VINCRISTINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABC-02 TRIAL', 'DRUG_GROUP = VINORELBINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABC-03 TRIAL', 'DRUG_GROUP = BLEOMYCIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABC-03 TRIAL', 'DRUG_GROUP = CARBOPLATIN', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ABC-03 TRIAL', 'DRUG_GROUP = CARMUSTINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABC-03 TRIAL', 'DRUG_GROUP = CISPLATIN', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ABC-03 TRIAL',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ABC-03 TRIAL', 'DRUG_GROUP = DOXORUBICIN', {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ABC-03 TRIAL', 'DRUG_GROUP = ETOPOSIDE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABC-03 TRIAL', 'DRUG_GROUP = NOT CHEMO', {'weight': 19}),\n",
       " ('MAPPED_REGIMEN = ABC-03 TRIAL', 'DRUG_GROUP = RITUXIMAB', {'weight': 8}),\n",
       " ('MAPPED_REGIMEN = ABC-03 TRIAL', 'DRUG_GROUP = STEROID', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ABC-03 TRIAL', 'DRUG_GROUP = VINCRISTINE', {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ABIRATERONE + EXEMESTANE',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ABIRATERONE + EXEMESTANE',\n",
       "  'DRUG_GROUP = DOCETAXEL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABIRATERONE + EXEMESTANE',\n",
       "  'DRUG_GROUP = EPIRUBICIN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ABIRATERONE + EXEMESTANE',\n",
       "  'DRUG_GROUP = FLUOROURACIL',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ABIRATERONE + EXEMESTANE',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ABIRATERONE + EXEMESTANE',\n",
       "  'DRUG_GROUP = PACLITAXEL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABIRATERONE + EXEMESTANE',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABIRATERONE + EXEMESTANE',\n",
       "  'DRUG_GROUP = TRASTUZUMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABIRATERONE + Enzalutamide',\n",
       "  'DRUG_GROUP = BICALUTAMIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABIRATERONE + Enzalutamide',\n",
       "  'DRUG_GROUP = DOCETAXEL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABIRATERONE + Enzalutamide',\n",
       "  'DRUG_GROUP = ENZALUTAMIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABIRATERONE + Enzalutamide',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = ABIRATERONE', {'weight': 28}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = AFATINIB', {'weight': 63}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = AFLIBERCEPT', {'weight': 33}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = ALEMTUZUMAB', {'weight': 17}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = ASPARAGINASE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = ATG', {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = AXITINIB', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = AZACITIDINE', {'weight': 8}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = BCG', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = BENDAMUSTINE', {'weight': 57}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = BEVACIZUMAB', {'weight': 243}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = BICALUTAMIDE', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = BLEOMYCIN', {'weight': 2797}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = BLINATUMOMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = BORTEZOMIB', {'weight': 159}),\n",
       " ('MAPPED_REGIMEN = ABVD',\n",
       "  'DRUG_GROUP = BRENTUXIMAB VEDOTIN',\n",
       "  {'weight': 185}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = BUSULFAN', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = CABAZITAXEL', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = CALCIUM FOLINATE', {'weight': 19}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = CAPECITABINE', {'weight': 1127}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = CARBOPLATIN', {'weight': 650}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = CARFILZOMIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = CARMUSTINE', {'weight': 19}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = CETRORELIX ACETATE', {'weight': 9}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = CETUXIMAB', {'weight': 1368}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = CHLORAMBUCIL', {'weight': 66}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = CISPLATIN', {'weight': 2338}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = CLADRIBINE', {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = CRIZOTINIB', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = CYCLOPHOSPHAMIDE', {'weight': 551}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = CYPROTERONE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = CYTARABINE', {'weight': 120}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = DABRAFENIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = DACARBAZINE', {'weight': 3263}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = DACTINOMYCIN', {'weight': 143}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = DASATINIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = DAUNORUBICIN', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = DEGARELIX', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = DENOSUMAB', {'weight': 30}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = DEXAMETHASONE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = DOCETAXEL', {'weight': 279}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = DOXORUBICIN', {'weight': 3881}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = ELOTUZUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = ENZALUTAMIDE', {'weight': 16}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = EPIRUBICIN', {'weight': 61}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = ERLOTINIB', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = ETOPOSIDE', {'weight': 1003}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = EVEROLIMUS', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = FLUCONAZOLE', {'weight': 32}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = FLUDARABINE', {'weight': 24}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = FLUOROURACIL', {'weight': 1777}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = FOLINIC ACID', {'weight': 18}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = FULVESTRANT', {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = GANETESPIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = GEFITINIB', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = GEMCITABINE', {'weight': 395}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = GOSERELIN', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = HYDROXYCARBAMIDE', {'weight': 16}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = IBRUTINIB', {'weight': 12}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = IDELALISIB', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = IFOSFAMIDE', {'weight': 579}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = IMATINIB', {'weight': 16}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = IPILIMUMAB', {'weight': 8}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = IRINOTECAN', {'weight': 390}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = LAPATINIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = LENALIDOMIDE', {'weight': 20}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = LEUPRORELIN', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ABVD',\n",
       "  'DRUG_GROUP = LIPOSOMAL DOXORUBICIN',\n",
       "  {'weight': 17}),\n",
       " ('MAPPED_REGIMEN = ABVD',\n",
       "  'DRUG_GROUP = LIPOSOMAL DOXORUBICIN (CAELYX)',\n",
       "  {'weight': 10}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = LOMUSTINE', {'weight': 9}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = MELPHALAN', {'weight': 17}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = MERCAPTOPURINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = MESNA', {'weight': 97}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = METHOTREXATE', {'weight': 36}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = MIFAMURTIDE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = MITOMYCIN', {'weight': 15}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = MITOXANTRONE', {'weight': 27}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = MULTIPLE', {'weight': 155}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = NAB-PACLITAXEL', {'weight': 10}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = NILOTINIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = NINTEDANIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = NIVOLUMAB', {'weight': 11}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = NOT CHEMO', {'weight': 9875}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = NOT MATCHED', {'weight': 117}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = OBINUTUZUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = OFATUMUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = OXALIPLATIN', {'weight': 989}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = PACLITAXEL', {'weight': 163}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = PAMIDRONATE', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = PANITUMUMAB', {'weight': 31}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = PATRITUMAB', {'weight': 9}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = PAZOPANIB', {'weight': 20}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = PEMBROLIZUMAB', {'weight': 20}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = PEMETREXED', {'weight': 30}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = PERTUZUMAB', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = POMALIDOMIDE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = PROCARBAZINE', {'weight': 66}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = RALTITREXED', {'weight': 16}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = RITUXIMAB', {'weight': 324}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = RUXOLITINIB', {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = SORAFENIB', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = STEROID', {'weight': 3727}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = SUNITINIB', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = TEMOZOLOMIDE', {'weight': 21}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = THALIDOMIDE', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = THIOTEPA', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = TOPOTECAN', {'weight': 36}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = TRABECTEDIN', {'weight': 91}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = TRAMETINIB', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = TRASTUZUMAB', {'weight': 23}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = TREMELIMUMAB', {'weight': 8}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = TRIAL', {'weight': 110}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = TRIPTORELIN', {'weight': 74}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = VANDETANIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = VEMURAFENIB', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = VINBLASTINE', {'weight': 3295}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = VINCRISTINE', {'weight': 864}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = VINFLUNINE', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = VINORELBINE', {'weight': 99}),\n",
       " ('MAPPED_REGIMEN = ABVD', 'DRUG_GROUP = ZOLEDRONIC ACID', {'weight': 31}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = BENDAMUSTINE', {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = BEVACIZUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = BLEOMYCIN', {'weight': 18}),\n",
       " ('MAPPED_REGIMEN = ABVD R',\n",
       "  'DRUG_GROUP = BRENTUXIMAB VEDOTIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = CALCIUM FOLINATE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = CAPECITABINE', {'weight': 8}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = CARBOPLATIN', {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = CETUXIMAB', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = CISPLATIN', {'weight': 27}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = CYCLOPHOSPHAMIDE', {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = CYTARABINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = DACARBAZINE', {'weight': 24}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = DACTINOMYCIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = DOCETAXEL', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = DOXORUBICIN', {'weight': 22}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = ETOPOSIDE', {'weight': 8}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = FLUDARABINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = FLUOROURACIL', {'weight': 21}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = GEMCITABINE', {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = IFOSFAMIDE', {'weight': 10}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = IRINOTECAN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = MESNA', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = METHOTREXATE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = MULTIPLE', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = NOT CHEMO', {'weight': 85}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = NOT MATCHED', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = OXALIPLATIN', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = PACLITAXEL', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = PANITUMUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = RALTITREXED', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = RITUXIMAB', {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = STEROID', {'weight': 28}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = TRASTUZUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = TRIAL', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = VINBLASTINE', {'weight': 26}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = VINCRISTINE', {'weight': 8}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = VINFLUNINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ABVD R', 'DRUG_GROUP = VINORELBINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = AFATINIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = ALEMTUZUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = ANASTROZOLE', {'weight': 11}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = AXITINIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = BENDAMUSTINE', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = BEVACIZUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = CAPECITABINE', {'weight': 23}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = CARBOPLATIN', {'weight': 47}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = CARMUSTINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = CETUXIMAB', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = CHLORAMBUCIL', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = CISPLATIN', {'weight': 14}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = CRIZOTINIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = CYCLOPHOSPHAMIDE', {'weight': 818}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = CYTARABINE', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = DACARBAZINE', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = DENOSUMAB', {'weight': 161}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = DOCETAXEL', {'weight': 320}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = DOXORUBICIN', {'weight': 41}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = EPIRUBICIN', {'weight': 819}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = ERIBULIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = ETOPOSIDE', {'weight': 11}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = EVEROLIMUS', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = FLUCONAZOLE', {'weight': 9}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = FLUOROURACIL', {'weight': 499}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = FULVESTRANT', {'weight': 198}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = GEFITINIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = GEMCITABINE', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = GOSERELIN', {'weight': 21}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = HYDROXYCARBAMIDE', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = IFOSFAMIDE', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = IPILIMUMAB', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = IRINOTECAN', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = LENALIDOMIDE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = LETROZOLE', {'weight': 32}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = LEUPRORELIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = MELPHALAN', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = MESNA', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = METHOTREXATE', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = MITOMYCIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = MULTIPLE', {'weight': 12}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = NOT CHEMO', {'weight': 891}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = NOT MATCHED', {'weight': 12}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = OBINUTUZUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = OXALIPLATIN', {'weight': 9}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = PACLITAXEL', {'weight': 188}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = PEMBROLIZUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = PEMETREXED', {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = PERTUZUMAB', {'weight': 22}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = PROCARBAZINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = RITUXIMAB', {'weight': 22}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = STEROID', {'weight': 433}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = TAMOXIFEN', {'weight': 18}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = TOPOTECAN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = TRASTUZUMAB', {'weight': 153}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = TRASTUZUMAB EMTANSINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = TRIAL', {'weight': 9}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = TRIPTORELIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = VEMURAFENIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = VINBLASTINE', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = VINCRISTINE', {'weight': 13}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = VINORELBINE', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AC', 'DRUG_GROUP = ZOLEDRONIC ACID', {'weight': 17}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)',\n",
       "  'DRUG_GROUP = BRENTUXIMAB VEDOTIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = CARBOPLATIN', {'weight': 24}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = CISPLATIN', {'weight': 9}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = CRIZOTINIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = DENOSUMAB', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = ERLOTINIB', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = ETOPOSIDE', {'weight': 13}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = FLUOROURACIL', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = GEFITINIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = GEMCITABINE', {'weight': 18}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = IRINOTECAN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = MESNA', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = NIVOLUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = NOT CHEMO', {'weight': 55}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = NOT MATCHED', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = OXALIPLATIN', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = PACLITAXEL', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = PEMETREXED', {'weight': 10}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = SORAFENIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = STEROID', {'weight': 16}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = TRASTUZUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = TRIAL', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = VINCRISTINE', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)', 'DRUG_GROUP = VINORELBINE', {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ACE (3 day)',\n",
       "  'DRUG_GROUP = ZOLEDRONIC ACID',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = BENDAMUSTINE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = BEVACIZUMAB',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = CAPECITABINE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = CARBOPLATIN',\n",
       "  {'weight': 12}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = CARMUSTINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)', 'DRUG_GROUP = CETUXIMAB', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = CHLORAMBUCIL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)', 'DRUG_GROUP = CISPLATIN', {'weight': 8}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = DACARBAZINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)', 'DRUG_GROUP = DOCETAXEL', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = DOXORUBICIN',\n",
       "  {'weight': 8}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = EPIRUBICIN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)', 'DRUG_GROUP = ETOPOSIDE', {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = FLUCONAZOLE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = FLUOROURACIL',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = GEMCITABINE',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = HYDROXYCARBAMIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = IFOSFAMIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)', 'DRUG_GROUP = IMATINIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = IRINOTECAN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = LIPOSOMAL DOXORUBICIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = LIPOSOMAL DOXORUBICIN (CAELYX)',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = METHOTREXATE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = MIFAMURTIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)', 'DRUG_GROUP = MULTIPLE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 71}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = OXALIPLATIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = PACLITAXEL',\n",
       "  {'weight': 11}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 11}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)', 'DRUG_GROUP = STEROID', {'weight': 11}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = TRASTUZUMAB',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)', 'DRUG_GROUP = TRIAL', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = VINCRISTINE',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ACE (germ cell)',\n",
       "  'DRUG_GROUP = VINORELBINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE', 'DRUG_GROUP = BEVACIZUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE', 'DRUG_GROUP = CARBOPLATIN', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE', 'DRUG_GROUP = CISPLATIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE', 'DRUG_GROUP = DOCETAXEL', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE', 'DRUG_GROUP = DOXORUBICIN', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE', 'DRUG_GROUP = ETOPOSIDE', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE', 'DRUG_GROUP = FLUOROURACIL', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE', 'DRUG_GROUP = GEMCITABINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE',\n",
       "  'DRUG_GROUP = LIPOSOMAL DOXORUBICIN (CAELYX)',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE', 'DRUG_GROUP = MITOMYCIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE', 'DRUG_GROUP = NOT CHEMO', {'weight': 13}),\n",
       " ('MAPPED_REGIMEN = ADE', 'DRUG_GROUP = PEMBROLIZUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE', 'DRUG_GROUP = RITUXIMAB', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE', 'DRUG_GROUP = STEROID', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE', 'DRUG_GROUP = TOPOTECAN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE', 'DRUG_GROUP = TRABECTEDIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = ALEMTUZUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = AZACITIDINE', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = BENDAMUSTINE', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = BEVACIZUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = BLEOMYCIN', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = BORTEZOMIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = CAPECITABINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = CARBOPLATIN', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = CISPLATIN', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = CYTARABINE', {'weight': 25}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = DAUNORUBICIN', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = DOXORUBICIN', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = EPIRUBICIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = ETOPOSIDE', {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = FLUDARABINE', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = FLUOROURACIL', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = GEMCITABINE', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5',\n",
       "  'DRUG_GROUP = HYDROXYCARBAMIDE',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = IDARUBICIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = IFOSFAMIDE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = IMATINIB', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = IRINOTECAN', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5',\n",
       "  'DRUG_GROUP = LIPOSOMAL DAUNORUBICIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5',\n",
       "  'DRUG_GROUP = LIPOSOMAL DOXORUBICIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = MERCAPTOPURINE', {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = METHOTREXATE', {'weight': 9}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = NOT CHEMO', {'weight': 50}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = NOT MATCHED', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = PACLITAXEL', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5',\n",
       "  'DRUG_GROUP = PEG-ASPARAGINASE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = PEMETREXED', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = RITUXIMAB', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = STEROID', {'weight': 15}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = TRIPTORELIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5', 'DRUG_GROUP = VINCRISTINE', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ADE 10+3+5',\n",
       "  'DRUG_GROUP = ZOLEDRONIC ACID',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = ALEMTUZUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = AZACITIDINE', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = BENDAMUSTINE', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = BLEOMYCIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = CAPECITABINE', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = CYTARABINE', {'weight': 11}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = DOXORUBICIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = FLUDARABINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = FLUOROURACIL', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = GEMCITABINE', {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = MERCAPTOPURINE', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = MIFAMURTIDE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = NOT CHEMO', {'weight': 14}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = NOT MATCHED', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = OXALIPLATIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = PAZOPANIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = RITUXIMAB', {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = STEROID', {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = TRIAL', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADE 8+3+5', 'DRUG_GROUP = VINCRISTINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADOC', 'DRUG_GROUP = AZACITIDINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADOC', 'DRUG_GROUP = CARBOPLATIN', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADOC', 'DRUG_GROUP = CISPLATIN', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADOC', 'DRUG_GROUP = ETOPOSIDE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADOC', 'DRUG_GROUP = FLUOROURACIL', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADOC', 'DRUG_GROUP = GEMCITABINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADOC', 'DRUG_GROUP = IFOSFAMIDE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADOC', 'DRUG_GROUP = IPILIMUMAB', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADOC', 'DRUG_GROUP = NOT CHEMO', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ADOC', 'DRUG_GROUP = PEMBROLIZUMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADOC', 'DRUG_GROUP = RITUXIMAB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ADOC', 'DRUG_GROUP = STEROID', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ADOC', 'DRUG_GROUP = VINCRISTINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AEZS-108', 'DRUG_GROUP = CARBOPLATIN', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AEZS-108', 'DRUG_GROUP = EPIRUBICIN', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AEZS-108', 'DRUG_GROUP = NOT CHEMO', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AEZS-108', 'DRUG_GROUP = OXALIPLATIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AEZS-108', 'DRUG_GROUP = PACLITAXEL', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AEZS-108', 'DRUG_GROUP = STEROID', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = ABIRATERONE', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = AFATINIB', {'weight': 18}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = AZACITIDINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = BCG', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = BENDAMUSTINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = BEVACIZUMAB', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = BICALUTAMIDE', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = BORTEZOMIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = CALCIUM FOLINATE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = CAPECITABINE', {'weight': 26}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = CARBOPLATIN', {'weight': 423}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = CERITINIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = CETUXIMAB', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = CHLORAMBUCIL', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = CISPLATIN', {'weight': 177}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = CRIZOTINIB', {'weight': 15}),\n",
       " ('MAPPED_REGIMEN = AFATINIB',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 14}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = CYTARABINE', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = DACARBAZINE', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = DACTINOMYCIN', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = DENOSUMAB', {'weight': 29}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = DOCETAXEL', {'weight': 25}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = DOXORUBICIN', {'weight': 12}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = EPIRUBICIN', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = ERLOTINIB', {'weight': 66}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = ETOPOSIDE', {'weight': 248}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = FLUCONAZOLE', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = FLUDARABINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = FLUOROURACIL', {'weight': 16}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = GEFITINIB', {'weight': 36}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = GEMCITABINE', {'weight': 203}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = HYDROXYCARBAMIDE', {'weight': 8}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = IFOSFAMIDE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = IMATINIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = IPILIMUMAB', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = IRINOTECAN', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = LAPATINIB', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = LENALIDOMIDE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = LEUPRORELIN', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = MERCAPTOPURINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = MESNA', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = MITOMYCIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = MULTIPLE', {'weight': 17}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = NINTEDANIB', {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = NIVOLUMAB', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = NOT CHEMO', {'weight': 697}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = NOT MATCHED', {'weight': 8}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = OXALIPLATIN', {'weight': 11}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = PACLITAXEL', {'weight': 36}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = PAMIDRONATE', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = PEMETREXED', {'weight': 209}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = RITUXIMAB', {'weight': 11}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = STEROID', {'weight': 282}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = STREPTOZOCIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = TEMSIROLIMUS', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = TOPOTECAN', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = TRASTUZUMAB', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = TRIAL', {'weight': 16}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = VINBLASTINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = VINCRISTINE', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = VINORELBINE', {'weight': 134}),\n",
       " ('MAPPED_REGIMEN = AFATINIB', 'DRUG_GROUP = ZOLEDRONIC ACID', {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = ABIRATERONE', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = AFLIBERCEPT', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = BEVACIZUMAB', {'weight': 31}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = BLEOMYCIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT',\n",
       "  'DRUG_GROUP = CALCIUM FOLINATE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT',\n",
       "  'DRUG_GROUP = CAPECITABINE',\n",
       "  {'weight': 184}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = CARBOPLATIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = CETUXIMAB', {'weight': 14}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = CISPLATIN', {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = DACTINOMYCIN', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = DOCETAXEL', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = DOXORUBICIN', {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = ENZALUTAMIDE', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = ETOPOSIDE', {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = FLUOROURACIL', {'weight': 75}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = FOLINIC ACID', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = GEMCITABINE', {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = IRINOTECAN', {'weight': 35}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = MITOMYCIN', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT',\n",
       "  'DRUG_GROUP = NAB-PACLITAXEL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = NOT CHEMO', {'weight': 223}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = NOT MATCHED', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = OXALIPLATIN', {'weight': 86}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = PACLITAXEL', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = PANITUMUMAB', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = RALTITREXED', {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = STEROID', {'weight': 65}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = TRIAL', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = VINBLASTINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT', 'DRUG_GROUP = VINORELBINE', {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT',\n",
       "  'DRUG_GROUP = ZOLEDRONIC ACID',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = ABIRATERONE',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = AFLIBERCEPT',\n",
       "  {'weight': 13}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = ASPARAGINASE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = AZACITIDINE',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = BCG',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = BENDAMUSTINE',\n",
       "  {'weight': 10}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = BEVACIZUMAB',\n",
       "  {'weight': 151}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = BLEOMYCIN',\n",
       "  {'weight': 12}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = BORTEZOMIB',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = BRENTUXIMAB VEDOTIN',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = CALCIUM FOLINATE',\n",
       "  {'weight': 15}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = CAPECITABINE',\n",
       "  {'weight': 1102}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = CARBOPLATIN',\n",
       "  {'weight': 40}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = CETUXIMAB',\n",
       "  {'weight': 106}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = CHLORAMBUCIL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = CISPLATIN',\n",
       "  {'weight': 38}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = CLADRIBINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 27}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = DACARBAZINE',\n",
       "  {'weight': 9}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = DAUNORUBICIN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = DENOSUMAB',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = DEXAMETHASONE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = DOCETAXEL',\n",
       "  {'weight': 14}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = DOXORUBICIN',\n",
       "  {'weight': 28}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = ENZALUTAMIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = EPIRUBICIN',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = ERLOTINIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = ETOPOSIDE',\n",
       "  {'weight': 20}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = FLUCONAZOLE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = FLUOROURACIL',\n",
       "  {'weight': 429}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = FOLINIC ACID',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = FULVESTRANT',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = GEFITINIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = GEMCITABINE',\n",
       "  {'weight': 38}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = HYDROXYCARBAMIDE',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = IBRUTINIB',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = IFOSFAMIDE',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = IMATINIB',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = IRINOTECAN',\n",
       "  {'weight': 197}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = LOMUSTINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = MERCAPTOPURINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = MESNA',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = MITOMYCIN',\n",
       "  {'weight': 18}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = MULTIPLE',\n",
       "  {'weight': 18}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = NAB-PACLITAXEL',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = NILOTINIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 1444}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = NOT MATCHED',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = OXALIPLATIN',\n",
       "  {'weight': 532}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = PACLITAXEL',\n",
       "  {'weight': 34}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = PANITUMUMAB',\n",
       "  {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = PAZOPANIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = PEMETREXED',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = RALTITREXED',\n",
       "  {'weight': 11}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 34}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 381}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = STREPTOZOCIN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = SUNITINIB',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = TOPOTECAN',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = TRABECTEDIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = TRASTUZUMAB',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = TRIAL',\n",
       "  {'weight': 17}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = TRIPTORELIN',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = VEMURAFENIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = VINBLASTINE',\n",
       "  {'weight': 10}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = VINCRISTINE',\n",
       "  {'weight': 15}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = VINORELBINE',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = AFLIBERCEPT + FU + IRINOTECAN',\n",
       "  'DRUG_GROUP = ZOLEDRONIC ACID',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = BENDAMUSTINE',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = BEVACIZUMAB',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = BLEOMYCIN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = BRENTUXIMAB VEDOTIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = CAPECITABINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = CARBOPLATIN',\n",
       "  {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = CISPLATIN',\n",
       "  {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 12}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = DACARBAZINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = DENOSUMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = DOXORUBICIN',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = EPIRUBICIN',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = ETOPOSIDE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = FLUDARABINE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = FLUOROURACIL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = GEFITINIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = GEMCITABINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = IRINOTECAN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = METHOTREXATE',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = MULTIPLE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = NAB-PACLITAXEL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 55}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = NOT MATCHED',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = OLAPARIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = PACLITAXEL',\n",
       "  {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = PAZOPANIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 11}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = RUXOLITINIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 8}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = TRASTUZUMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = TRIAL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = VINBLASTINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed AM 1, 2 or 3',\n",
       "  'DRUG_GROUP = VINCRISTINE',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = BENDAMUSTINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = BEVACIZUMAB',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = BRENTUXIMAB VEDOTIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = CARBOPLATIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = CISPLATIN',\n",
       "  {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = DOXORUBICIN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = ETOPOSIDE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = FLUOROURACIL',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = HYDROXYCARBAMIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = IPILIMUMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = METHOTREXATE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 29}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = VINCRISTINE',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed BM 1, 2 or 3',\n",
       "  'DRUG_GROUP = VINORELBINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed Pre Phase',\n",
       "  'DRUG_GROUP = BEVACIZUMAB',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed Pre Phase',\n",
       "  'DRUG_GROUP = CHLORAMBUCIL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed Pre Phase',\n",
       "  'DRUG_GROUP = CISPLATIN',\n",
       "  {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed Pre Phase',\n",
       "  'DRUG_GROUP = DACARBAZINE',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed Pre Phase',\n",
       "  'DRUG_GROUP = DOXORUBICIN',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed Pre Phase',\n",
       "  'DRUG_GROUP = FOLINIC ACID',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed Pre Phase',\n",
       "  'DRUG_GROUP = IBRUTINIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed Pre Phase',\n",
       "  'DRUG_GROUP = IRINOTECAN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed Pre Phase',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 12}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed Pre Phase',\n",
       "  'DRUG_GROUP = NOT MATCHED',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed Pre Phase',\n",
       "  'DRUG_GROUP = OXALIPLATIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed Pre Phase',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed Pre Phase',\n",
       "  'DRUG_GROUP = TRIAL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed Pre Phase',\n",
       "  'DRUG_GROUP = VINBLASTINE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALCL ALCL 99 Closed Pre Phase',\n",
       "  'DRUG_GROUP = VINCRISTINE',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB (Intravenous)',\n",
       "  'DRUG_GROUP = AZACITIDINE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB (Intravenous)',\n",
       "  'DRUG_GROUP = CLADRIBINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB (Intravenous)',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB (Intravenous)',\n",
       "  'DRUG_GROUP = FLUDARABINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB (Intravenous)',\n",
       "  'DRUG_GROUP = MERCAPTOPURINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB (Intravenous)',\n",
       "  'DRUG_GROUP = METHOTREXATE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB (Intravenous)',\n",
       "  'DRUG_GROUP = PEG-ASPARAGINASE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB (Intravenous)',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = DOXORUBICIN',\n",
       "  {'weight': 9}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = METHOTREXATE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 8}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = VINCRISTINE',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE',\n",
       "  'DRUG_GROUP = ASPARAGINASE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE',\n",
       "  'DRUG_GROUP = BORTEZOMIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE',\n",
       "  'DRUG_GROUP = FLUDARABINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE',\n",
       "  'DRUG_GROUP = GEMCITABINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE',\n",
       "  'DRUG_GROUP = NILOTINIB',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE',\n",
       "  'DRUG_GROUP = PEG-ASPARAGINASE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = ALEMTUZUMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = AZACITIDINE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = CARBOPLATIN',\n",
       "  {'weight': 8}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = CISPLATIN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = DACTINOMYCIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = ETOPOSIDE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = FLUCONAZOLE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = GEMCITABINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = IDARUBICIN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = MERCAPTOPURINE',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = MESNA',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = METHOTREXATE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 11}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = PEMETREXED',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN',\n",
       "  'DRUG_GROUP = VINCRISTINE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = AMSACRINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = ARSENIC TRIOXIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = ASPARAGINASE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = AZACITIDINE',\n",
       "  {'weight': 16}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = BENDAMUSTINE',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = BUSULFAN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = CARBOPLATIN',\n",
       "  {'weight': 12}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = CETUXIMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = CHLORAMBUCIL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = CISPLATIN',\n",
       "  {'weight': 9}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 27}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = DACTINOMYCIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = DASATINIB',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = DAUNORUBICIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = DENOSUMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = DOXORUBICIN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = EPIRUBICIN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = ETOPOSIDE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = FLUDARABINE',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = FLUOROURACIL',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = GANETESPIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = GEMCITABINE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = HYDROXYCARBAMIDE',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = IBRUTINIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = IDARUBICIN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = IDELALISIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = IFOSFAMIDE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = IMATINIB',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = IPILIMUMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = IRINOTECAN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = LENALIDOMIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = MELPHALAN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = MERCAPTOPURINE',\n",
       "  {'weight': 12}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = MESNA',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = METHOTREXATE',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = MULTIPLE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = NAB-PACLITAXEL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = NILOTINIB',\n",
       "  {'weight': 10}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 61}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = NOT MATCHED',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = OFATUMUMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = OXALIPLATIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = PACLITAXEL',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = PEG-ASPARAGINASE',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = PEMETREXED',\n",
       "  {'weight': 17}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 15}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 13}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = TEMOZOLOMIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = TRETINOIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = VINBLASTINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = VINCRISTINE',\n",
       "  {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + BUSULFAN + FLUDARABINE',\n",
       "  'DRUG_GROUP = VINORELBINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + ETOPOSIDE',\n",
       "  'DRUG_GROUP = BENDAMUSTINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + ETOPOSIDE',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 15}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + ETOPOSIDE',\n",
       "  'DRUG_GROUP = DAUNORUBICIN',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + ETOPOSIDE',\n",
       "  'DRUG_GROUP = HYDROXYCARBAMIDE',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + ETOPOSIDE',\n",
       "  'DRUG_GROUP = IDELALISIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + ETOPOSIDE',\n",
       "  'DRUG_GROUP = IMATINIB',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + ETOPOSIDE',\n",
       "  'DRUG_GROUP = METHOTREXATE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + ETOPOSIDE',\n",
       "  'DRUG_GROUP = MITOXANTRONE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + ETOPOSIDE',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + ETOPOSIDE',\n",
       "  'DRUG_GROUP = OFATUMUMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + ETOPOSIDE',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + ETOPOSIDE',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE',\n",
       "  'DRUG_GROUP = BORTEZOMIB',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE',\n",
       "  'DRUG_GROUP = DAUNORUBICIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE',\n",
       "  'DRUG_GROUP = DOXORUBICIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE',\n",
       "  'DRUG_GROUP = FULVESTRANT',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE',\n",
       "  'DRUG_GROUP = LENALIDOMIDE',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE',\n",
       "  'DRUG_GROUP = MELPHALAN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE',\n",
       "  'DRUG_GROUP = NAB-PACLITAXEL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE',\n",
       "  'DRUG_GROUP = NILOTINIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE',\n",
       "  'DRUG_GROUP = THALIDOMIDE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + LEAM',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + LEAM',\n",
       "  'DRUG_GROUP = DOXORUBICIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + LEAM',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + LEAM',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + LEAM',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = ADI-PEG 20',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = ALEMTUZUMAB',\n",
       "  {'weight': 8}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = ARSENIC TRIOXIDE',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = ASPARAGINASE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = AZACITIDINE',\n",
       "  {'weight': 12}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = BENDAMUSTINE',\n",
       "  {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = BEVACIZUMAB',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = BLEOMYCIN',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = BLINATUMOMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = BORTEZOMIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = BOSUTINIB',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = BUSULFAN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = CAPECITABINE',\n",
       "  {'weight': 13}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = CARBOPLATIN',\n",
       "  {'weight': 21}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = CARMUSTINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = CETUXIMAB',\n",
       "  {'weight': 10}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = CHLORAMBUCIL',\n",
       "  {'weight': 9}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = CISPLATIN',\n",
       "  {'weight': 14}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = CLADRIBINE',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = CLOFARABINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 22}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 89}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = DACARBAZINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = DASATINIB',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = DAUNORUBICIN',\n",
       "  {'weight': 13}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = DOCETAXEL',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = DOXORUBICIN',\n",
       "  {'weight': 16}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = ENZALUTAMIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = EPIRUBICIN',\n",
       "  {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = ERLOTINIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = ETOPOSIDE',\n",
       "  {'weight': 11}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = FLUDARABINE',\n",
       "  {'weight': 17}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = FLUOROURACIL',\n",
       "  {'weight': 9}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = GANETESPIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = GEMCITABINE',\n",
       "  {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = HYDROXYCARBAMIDE',\n",
       "  {'weight': 20}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = IBRUTINIB',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = IDARUBICIN',\n",
       "  {'weight': 12}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = IFOSFAMIDE',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = IMATINIB',\n",
       "  {'weight': 11}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = IRINOTECAN',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = LENALIDOMIDE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = LIPOSOMAL DOXORUBICIN (CAELYX)',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = MERCAPTOPURINE',\n",
       "  {'weight': 22}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = MESNA',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = METHOTREXATE',\n",
       "  {'weight': 32}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = MITOMYCIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = MITOXANTRONE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = MULTIPLE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = NILOTINIB',\n",
       "  {'weight': 16}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = NIVOLUMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 176}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = NOT MATCHED',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = OFATUMUMAB',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = OXALIPLATIN',\n",
       "  {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = PACLITAXEL',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = PEG-ASPARAGINASE',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = PEMETREXED',\n",
       "  {'weight': 10}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = PIXANTRONE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = PREDNISOLONE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 34}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = RUXOLITINIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 48}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = THALIDOMIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = TOPOTECAN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = TRASTUZUMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = TRETINOIN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = TRIAL',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = TRIPTORELIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = VEMURAFENIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = VINBLASTINE',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = VINCRISTINE',\n",
       "  {'weight': 28}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = VINORELBINE',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + FLUDARABINE + MELPHALAN',\n",
       "  'DRUG_GROUP = ZOLEDRONIC ACID',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + PENTOSTATIN',\n",
       "  'DRUG_GROUP = DAUNORUBICIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + PENTOSTATIN',\n",
       "  'DRUG_GROUP = FLUDARABINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB + PENTOSTATIN',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB METHYLPREDNISOLONE',\n",
       "  'DRUG_GROUP = ALEMTUZUMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB METHYLPREDNISOLONE',\n",
       "  'DRUG_GROUP = AZACITIDINE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB METHYLPREDNISOLONE',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB METHYLPREDNISOLONE',\n",
       "  'DRUG_GROUP = ETOPOSIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB METHYLPREDNISOLONE',\n",
       "  'DRUG_GROUP = HYDROXYCARBAMIDE',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB METHYLPREDNISOLONE',\n",
       "  'DRUG_GROUP = IDARUBICIN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB METHYLPREDNISOLONE',\n",
       "  'DRUG_GROUP = IMATINIB',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB METHYLPREDNISOLONE',\n",
       "  'DRUG_GROUP = MERCAPTOPURINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB METHYLPREDNISOLONE',\n",
       "  'DRUG_GROUP = METHOTREXATE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB METHYLPREDNISOLONE',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB METHYLPREDNISOLONE',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALEMTUZUMAB METHYLPREDNISOLONE',\n",
       "  'DRUG_GROUP = VINCRISTINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3 FLAD Phase IV',\n",
       "  'DRUG_GROUP = CARBOPLATIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3 FLAD Phase IV',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3 FLAD Phase IV',\n",
       "  'DRUG_GROUP = DAUNORUBICIN',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3 FLAD Phase IV',\n",
       "  'DRUG_GROUP = ETOPOSIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3 FLAD Phase IV',\n",
       "  'DRUG_GROUP = HYDROXYCARBAMIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3 FLAD Phase IV',\n",
       "  'DRUG_GROUP = MERCAPTOPURINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3 FLAD Phase IV',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 6}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3 FLAD Phase IV',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3 FLAD Phase IV',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: Alt HR Con:Wk 6 ErwHDMtx',\n",
       "  'DRUG_GROUP = IDELALISIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = ARSENIC TRIOXIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = BENDAMUSTINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 8}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = DASATINIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = DAUNORUBICIN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = FLUCONAZOLE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = FLUDARABINE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = GANETESPIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = HYDROXYCARBAMIDE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = LENALIDOMIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = METHOTREXATE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = NILOTINIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = OXALIPLATIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = TRETINOIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: HR Indn: Wk 1-4 (PegAsp)',\n",
       "  'DRUG_GROUP = VEMURAFENIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: Maint: Wk 1-4 (cycle 8)',\n",
       "  'DRUG_GROUP = METHOTREXATE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: Prot D Conditioning',\n",
       "  'DRUG_GROUP = CAPECITABINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: Prot D Conditioning',\n",
       "  'DRUG_GROUP = CLADRIBINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: Prot D Conditioning',\n",
       "  'DRUG_GROUP = DASATINIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: Prot D Conditioning',\n",
       "  'DRUG_GROUP = FLUOROURACIL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: Prot D Conditioning',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: Prot D Conditioning',\n",
       "  'DRUG_GROUP = VINCRISTINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx',\n",
       "  'DRUG_GROUP = CLADRIBINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx',\n",
       "  'DRUG_GROUP = FLUDARABINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx',\n",
       "  'DRUG_GROUP = GEMCITABINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx',\n",
       "  'DRUG_GROUP = IMATINIB',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx',\n",
       "  'DRUG_GROUP = METHOTREXATE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx',\n",
       "  'DRUG_GROUP = NILOTINIB',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx',\n",
       "  'DRUG_GROUP = PEMETREXED',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx',\n",
       "  'DRUG_GROUP = PENTOSTATIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx',\n",
       "  'DRUG_GROUP = PERTUZUMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx',\n",
       "  'DRUG_GROUP = VINCRISTINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons Wk 5',\n",
       "  'DRUG_GROUP = BENDAMUSTINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons Wk 5',\n",
       "  'DRUG_GROUP = CHLORAMBUCIL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons Wk 5',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons Wk 5',\n",
       "  'DRUG_GROUP = DOCETAXEL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons Wk 5',\n",
       "  'DRUG_GROUP = GEMCITABINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons Wk 5',\n",
       "  'DRUG_GROUP = IBRUTINIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons Wk 5',\n",
       "  'DRUG_GROUP = IDARUBICIN',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons Wk 5',\n",
       "  'DRUG_GROUP = MERCAPTOPURINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons Wk 5',\n",
       "  'DRUG_GROUP = METHOTREXATE',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons Wk 5',\n",
       "  'DRUG_GROUP = NILOTINIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons Wk 5',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons Wk 5',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons Wk 5',\n",
       "  'DRUG_GROUP = STEROID',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons Wk 5',\n",
       "  'DRUG_GROUP = VINCRISTINE',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons: Wk 7-8',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons: Wk 7-8',\n",
       "  'DRUG_GROUP = DASATINIB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons: Wk 7-8',\n",
       "  'DRUG_GROUP = METHOTREXATE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons: Wk 7-8',\n",
       "  'DRUG_GROUP = NOT CHEMO',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons: Wk 7-8',\n",
       "  'DRUG_GROUP = PENTOSTATIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Cons: Wk 7-8',\n",
       "  'DRUG_GROUP = RITUXIMAB',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = ALEMTUZUMAB',\n",
       "  {'weight': 4}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = ATG',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = AZACITIDINE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = BENDAMUSTINE',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = BORTEZOMIB',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = CARBOPLATIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = CETUXIMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = CHLORAMBUCIL',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = CISPLATIN',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = CLADRIBINE',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = CYCLOPHOSPHAMIDE',\n",
       "  {'weight': 12}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = CYTARABINE',\n",
       "  {'weight': 24}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = DAUNORUBICIN',\n",
       "  {'weight': 3}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = DENOSUMAB',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = DOCETAXEL',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = DOXORUBICIN',\n",
       "  {'weight': 5}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = EPIRUBICIN',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = ERLOTINIB',\n",
       "  {'weight': 2}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = ETOPOSIDE',\n",
       "  {'weight': 1}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = FLUDARABINE',\n",
       "  {'weight': 7}),\n",
       " ('MAPPED_REGIMEN = ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp)',\n",
       "  'DRUG_GROUP = GEMCITABINE',\n",
       "  {'weight': 2}),\n",
       " ...]"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "table = pd.merge(tables['sact_regimen'],tables['sact_drug_detail'],\n",
    "                 how='right')\n",
    "table[\"LEFT\"] = \"MAPPED_REGIMEN = \" + table[\"MAPPED_REGIMEN\"].astype(str)\n",
    "table[\"RIGHT\"] = \"DRUG_GROUP = \" + table[\"DRUG_GROUP\"].astype(str)\n",
    "\n",
    "grouped = table.groupby([\"LEFT\", \"RIGHT\"]).size()\n",
    "edges, weights = np.array(grouped.index), np.array(grouped)\n",
    "\n",
    "G = nx.DiGraph()\n",
    "G.add_edges_from(edges)\n",
    "\n",
    "nx.set_edge_attributes(G, dict(zip(edges, weights)), 'weight')\n",
    "\n",
    "list(nx.to_edgelist(G))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "nx.draw_networkx(G.subgraph(list(nx.all_neighbors(G, \n",
    "    \"MAPPED_REGIMEN = BLEOMYCIN\")).append(\"MAPPED_REGIMEN = BLEOMYCIN\")), with_labels=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "def how_many_per(big_group, small_group):\n",
    "    table = tables['sact_' + small_group.lower()]\n",
    "    grouped = table.groupby(\"MERGED_\" + big_group.upper() + \"_ID\").size()\n",
    "    print(grouped.describe())\n",
    "    plt.hist(grouped, bins=np.max(grouped))\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "count    299727.000000\n",
      "mean          1.574496\n",
      "std           1.044936\n",
      "min           1.000000\n",
      "25%           1.000000\n",
      "50%           1.000000\n",
      "75%           2.000000\n",
      "max          18.000000\n",
      "dtype: float64\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "how_many_per('tumour', 'regimen')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "levels = ['patient', 'tumour', 'regimen', 'cycle', 'drug_detail']\n",
    "ID_graph = nx.DiGraph()\n",
    "for i in range(len(levels)-1):\n",
    "    table = pd.merge(tables['sact_' + levels[i]], tables['sact_' + levels[i+1]],\n",
    "                     how='right')[[\"MERGED_\" + levels[i].upper() + \"_ID\",\n",
    "                                   \"MERGED_\" + levels[i+1].upper() + \"_ID\"]]\n",
    "    edges = pd.DataFrame()\n",
    "    edges['left'] = levels[i]+\"_\"+table[\"MERGED_\" + levels[i].upper() + \"_ID\"].astype(str)\n",
    "    edges['right'] = levels[i+1]+\"_\"+table[\"MERGED_\" + levels[i+1].upper() + \"_ID\"].astype(str)\n",
    "    ID_graph.add_edges_from(edges.values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "date_titles = [None, None,    # get from av tables\n",
    "               \"START_DATE_OF_REGIMEN\", \"START_DATE_OF_CYCLE\", \"ADMINISTRATION_DATE\"]\n",
    "for i in range(2, len(levels)):\n",
    "    pos_df = pd.DataFrame()\n",
    "    pos_df[\"node\"] = levels[i] + \"_\" + tables['sact_' + levels[i].lower()][\n",
    "        \"MERGED_\" + levels[i].upper() + \"_ID\"].astype(str)\n",
    "    pos_df[\"time\"]=tables['sact_' + levels[i].lower()][\n",
    "        date_titles[i]].astype(int)\n",
    "    pos_df[\"level\"]=i\n",
    "    pos_dict = dict(zip(pos_df.node, list(zip(pos_df[\"level\"], pos_df[\"time\"]))))\n",
    "    nx.set_node_attributes(ID_graph, pos_dict, 'position')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "def plot_path(tumour_id):\n",
    "    path = nx.descendants(ID_graph,'tumour_'+str(tumour_id))\n",
    "    path_graph = ID_graph.subgraph(path)\n",
    "    pos_dict = nx.get_node_attributes(path_graph, 'position')\n",
    "    fig = plt.figure(figsize=(12,8))\n",
    "    nx.draw_networkx(path_graph, pos_dict)\n",
    "    plt.axis('off')\n",
    "    plt.gca().invert_yaxis()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 864x576 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_path(10000006)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.5.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
